Category: TCD MENA

02 May 2017

TCD joins EOH as the group grows with strategic changes taking effect in May 2017

We are delighted to share the following significant changes and positive developments which took place recently within the TCD Group.

New Ownership

EOH, a JSE-listed South African based Knowledge Management group, have been in negotiation with the TCD Group since the last quarter of 2015, sharing the strategic objective to expand in the field of healthcare. EOH consists of a diverse portfolio of specialised industries in 21 countries across four continents.

The groups came to agreement in October 2016 and the transaction was completed in February 2017. EOH Holdings is now the 100% shareholder of the TCD Group of companies. We are excited by this positive development which opens many new horizons through the global profile of our new proudly South African owners.

The EOH philosophy involves sustaining successful acquisitions by building upon the inherent culture. The TCD Group will remain easily recognisable, building on our rich legacy, striving as always for continuous improvement.

Expansion of the TCD Group

The rapid evolution of the TCD Group expanded the original Triclinium into a full-service CRO (Contract Research Organisation), with a growing range of services and geographical footprint. Triclinium’s sister companies, within the TCD Group now consists of:

  • TCD Outcomes Research: The TCD Group developed a Health Economics and Outcomes Research (HEOR) organisation, through an acquisition of HeXor (a late phase development and pharmacoeconomics company), combined with the Late Phase Clinical Development expertise of TCD.
  • TCD e-Clinical Solutions: The TCD Group created an e-Clinical Solutions division which includes Software as a Service solution. TCD e-Clinical Solutions is focused around improving the outcome of clinical trials from a quality and efficiency perspective. Services include Electronic Data Capture (EDC), Electronic Medical Records (EMR), Electronic Patient Reported Outcomes (ePRO), Electronic Clinical Outcome Assessments (eCOA) and Mobile Health (mHealth), etc.
  • TCD Global Data Services: The TCD Group established and consolidated its Data Management and Biostatistics division under the TCD GDS brand, which is spearheaded out of South Africa and Bangalore, India.
  • TCD-MENA: The TCD Group established a full-service CRO based in Cairo, Egypt through a Joint Venture to focus on the Middle East and North Africa region.
  • PharmaLTX: The TCD Group established a software development company which specialises in software solutions in the wider health care sector such as partnering with Ministries of Health, Regulatory agencies, Institutional Review Boards, Universities, Clinical Research Centres, etc.


New TCD Group Chairman

The mandate to meld the member companies into a synergistic group has been entrusted to Dr Tienie Stander, founder of HeXor Pty Ltd., current Managing Director of TCD Outcomes Research, and now also the inaugural Chairman of the TCD Group.

Change in Managing Director of Triclinium Clinical Development

To those who know the company well, the most visible change is that after 17 years at the helm, founder Victor Strugo will relinquish the position of Managing Director to Abraham van Wyk, effective 1st May, 2017. Abraham has been increasingly involved in TCD executive functions since 2014 and his promotion is fully endorsed by TCD’s Board of Directors.

Victor will nevertheless remain active and visible in the new role of TCD Group Strategic Adviser, facilitating a smooth management transition, supporting key projects and developing new horizons for the company that he created in February 2000.

Our electronic media will be updated accordingly over time. We look forward to maintaining and strengthening our association with your organisation through this transition and to offer an ever-improving and broadening range of services in the years ahead.

For queries or more information, contact us at

26 Apr 2017
Tienie Stander, CEO of TCD Outcome Research welcoming Hanaa Abdel-Maguid, Managing Director of TCD MENA and TCD MENA’s super team in the opening ceremony

TCD MENA launch a major success

The TCD MENA launch took place on Tuesday, April 4, 2017 at the JW Marriott, Hall Tutankhamun 3, Ring Road-Cairo, Egypt. The event themed, “Partners In Innovation” was well received by those attending the launch. The attendees provided positive feedback and informative suggestions on future initiatives. They included representatives from local and multinational pharmaceutical companies such as Pharco Pharmaceuticals, Eva Pharma, Takeda, Pfizer and Novartis. Other attendees included professors at the faculty of medicine, members of the ethics committee as well as members from the clinical research centre in Alexandria.

The event took on the form of a panel discussion. Some of the attendees, such as Prof Dr Nihal El-Habachi, the executive academic director of Alexandria Clinical Research Centre, was representing the CRCs in Egypt. Prof Dr Dina Shoukry, the chairman of the National Research Ethics Committee and Maha Ghanem, professor of Forensic Medicine and Clinical Toxicology, both representing the EC, were asked to disclose their challenges and expectations within the CRO industry. Other known icons, such as Dr Imam Waked, professor in medicine in the NLI in Egypt and Dr Sherine Helmy, the vice president of Pharco Pharmaceuticals, had clearly emphasised the role of PIs in Egypt during the discussion.

The following topics were addressed: Institute/site roles and responsibilities, CRC roles and responsibilities, ethics committee roles and responsibilities, RHD-MOH roles and responsibilities, principal investigator’s roles and responsibilities, sponsor roles and responsibilities as well as academia’s roles and responsibilities. Dr Tienie Stander, managing director of  TCD Outcomes Research addressed challenges and expectations during his presentation: How will TCD MENA address challenges to meet expectations of our innovation stakeholders?

Dr Osama Fekry Ahmed, data manager from Pfizer (Egypt and Sudan) commented on the event: “It was a great idea to gather varieties of interested people in clinical research presenting the role of CROs in developing and initiating research and how they can share with the community of academic staff and clinical investigator, the building up of GCP concept; How can clinical trials positively impact their community and introduce the chance to be part of multinational trials. Also, it emphasised the concept of good research for good health”.

Dr Ilham Youssry, professor of Pediatrics and Pediatric Hematology, Faculty of Medicine, Cairo University also commented on the event: “The event did meet my expectations. TCD MENA has succeeded to deliver the message of a CRO’s role. In order to fulfil the market requirements, I suggest that you share fundraising with the researchers to support other researchers outside the interest of pharmaceutical companies” she also added, “Try to conduct an awareness program to spread the importance of the research message among the community”.

We would like to thank those attending the launch and commit to building on the foundations laid during the panel discussions. TCD MENA is dedicated to benefiting humanity by providing innovative cures through partnerships with all research & development stakeholders.

What Makes Us Different?

  • Sponsor Perspective
  • Flexible Business Models
  • Digital Capabilities
  • End-To-End Services

(Clinical Development, Product Registration, Commercialization)

  • Partners in Innovation.


Tienie Stander, CEO of TCD Outcome Research welcoming Hanaa Abdel-Maguid, Managing Director of TCD MENA and TCD MENA’s super team in the opening ceremony
Dr Tienie Stander, managing director of TCD Outcomes Research welcoming Hanaa Abdel-Maguid, managing director of TCD MENA and TCD MENA’s super team in the opening ceremony.

For a detailed video on the event and proceedings, visit


20 Feb 2017

TCD MENA to sponsor the Alex Clinical Research Networking Forum in Egypt

We are proud to announce that TCD MENA will be a sponsor at the Alex Clinical Research Networking Forum that will be conducted on Tuesday 21 Feb 2017 at the Alexandria University in Egypt. The event is themed: Potential for Egypt to take a leadership role in clinical research for the whole region: opportunities and challenges. Dr Hanaa Abdel-Maguid, managing director of TCD MENA will be presenting at the event. We at TCD South Africa are proud to be associated with this event and look forward to the insight it will bring to the Industry and to the MENA region.


31 Jan 2017

TCD MENA officially registered as CRO in Egypt

We are proud to announce that TCD MENA is now officially registered as a CRO in Egypt. Complementing TCD SA’s long-standing outreach into sub-Saharan and West Africa, TCD MENA was recently established in Heliopolis, Cairo to extend the provision of TCD’s clinical development services to clients looking to conduct research in the Middle East and North Africa (MENA) region.

The TCD MENA team has extensive clinical research experience in managing global clinical trials with sites in Egypt and the MENA region, as well as managing bioequivalence studies accepted by WHO, FDA and EU. Their expertise covers various therapeutic areas, including Oncology, Hepatology, Internal Medicine, Gynaecology and chronic diseases with strong relationships with KOLs across Egypt and the MENA region. Services include Regulatory Affairs, Clinical Operations, Project Management, Pharmacovigilance, Data Management, Biostatistics and Medical Writing.

We at TCD South Africa are excited about this long-standing partnership with TCD MENA, and in walking this road for the benefit of humanity.